Stock Overview
Guardant Health Inc (GH)
NASDAQ · Healthcare · Diagnostics & Research
Guardant Health Inc is a Healthcare company with a market capitalization of $19.79B.
Market Cap
$19.79B
Price/Sales
18.3
Price/Book
55.7
EV/EBITDA
-5.4
Beta
1.62
EPS (TTM)
$-3.40
Profit Margin
-40.1%
ROE
-4584.0%
52W High
$151.85
52W Low
$40.35
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Revenue
$982.02M
Gross Profit
$633.01M
Operating Income
-$436.30M
Net Income
-$416.28M
Free Cash Flow
-$233.07M
Total Debt
$1.50B
Cash & Equivalents
$378.20M
Shareholder Equity
-$99.31M
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 7, 2026 | $-0.45 | $-0.47 | +5.0% |
| Q4 2025 | February 19, 2026 | $-0.50 | $-0.78 | +35.5% |
| Q3 2025 | October 29, 2025 | $-0.39 | $-0.79 | +50.6% |
| Q2 2025 | July 30, 2025 | $-0.44 | $-0.72 | +38.9% |
| Q1 2025 | April 30, 2025 | $-0.49 | $-0.85 | +42.4% |
| Q4 2024 | February 20, 2025 | $-0.62 | $-0.50 | -23.1% |
Other Diagnostics & Research Stocks
Frequently Asked Questions
What is Guardant Health Inc's market cap?
As of June 29, 2026, Guardant Health Inc (GH) has a market capitalization of $19.79B.
Does Guardant Health Inc pay a dividend?
Guardant Health Inc does not currently pay a dividend.
What sector is GH in?
Guardant Health Inc is in the Healthcare sector, specifically the Diagnostics & Research industry.
What was Guardant Health Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Guardant Health Inc reported revenue of $982.02M and net income of -$416.28M.
Ask your own questions about GH
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.